If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,248.00    0.00 (0.00%)
Bid:
2,254.00
Ask:
2,288.00
Spread: 34.00 (1.508%)
Market Cap: £1.49b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Board Update

26 Feb 2009 07:00

RNS Number : 8965N
Genus PLC
26 February 2009
 



For immediate release 26 February 2009

Genus plc 

("Genus" or "the Company")

Board Update

Genus, a world leading animal genetics company, today announces that John Worby has been appointed as Finance Director of the Company with immediate effect. Mr Worby replaces Martin Boden who will be leaving the Company today to pursue other opportunities. John Worby joined the Board of the Company in September 2004 when he also became Chairman of the Audit Committee. Genus intends to strengthen the non executive representation on the Board by recruiting a replacement Audit Committee Chairman and enhancing the international commercial experience of the Board, particularly in emerging markets. A further announcement on this matter will be made in due course.

For further information please contact: Genus plc Tel: 01256 345 970 John Hawkins, Chairman

Buchanan Communications Tel: 020 7466 5000 Charles Ryland Isabel Podda Jennie Spivey About Genus Genus creates advances to animal breeding through biotechnology and sells added value products for livestock farming and food producers. Its non-genetically modified organism technology is applicable across all livestock species but is only commercialised by Genus in the bovine and porcine farming sectors. Genus' worldwide sales are made in seventy countries under the trade marks "ABS" (dairy and beef cattle) and "PIC" (pigs) and comprise semen and breeding animals with superior genetics to those animals currently in production. Customers' animals produce offspring with greater production efficiency, milk and meat output and quality and use these to supply the global dairy and meat supply chain. The Group's competitive edge has been created from the ownership and control of proprietary lines of breeding animals, the biotechnology used to improve them and its global production and distribution network. Headquartered in Basingstoke, England, Genus companies operate in 30 countries on six continents, with research laboratories located in Madison, Wisconsin, USA.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADGGZZNKMGLZM
Date   Source Headline
1st Apr 20157:00 amRNSCompletion of acquisition
31st Mar 20154:04 pmRNSTotal Voting Rights
19th Mar 20155:46 pmRNSDirector/PDMR Shareholding
12th Mar 20152:09 pmRNSDirector/PDMR Shareholding
9th Mar 20151:24 pmRNSDirector Declaration
27th Feb 20152:00 pmRNSTotal Voting Rights
24th Feb 201511:00 amRNSHolding(s) in Company
24th Feb 20157:00 amRNSInterim Results
16th Feb 20157:00 amRNSAcquisition of 51% of In Vitro Brasil
2nd Feb 20151:22 pmRNSBlock Listing Six Monthly Return
31st Dec 201412:01 pmRNSTotal Voting Rights
12th Dec 201410:44 amRNSDirector/PDMR Shareholding
1st Dec 20144:36 pmRNSTotal Voting Rights
21st Nov 20144:03 pmRNSDirector/PDMR Shareholding
14th Nov 20143:42 pmRNSResult of AGM
14th Nov 20147:00 amRNSTrading Update
31st Oct 201412:20 pmRNSTotal Voting Rights
22nd Oct 20149:29 amRNSDirector/PDMR Shareholding
10th Oct 20145:58 pmRNSHolding(s) in Company
8th Oct 20143:47 pmRNSAnnual Report and Annual General Meeting
3rd Sep 20147:00 amRNSPreliminary Results
3rd Sep 20147:00 amRNSPorcine Multiplication Agreement in China
29th Aug 20143:08 pmRNSTotal Voting Rights
1st Aug 20142:00 pmRNSBlock Listing 6 Monthly Return
8th Jul 20143:34 pmRNSHolding(s) in Company
7th Jul 20148:42 amRNSHolding(s) in Company
4th Jul 20141:43 pmRNSHolding(s) in Company
2nd Jul 20145:03 pmRNSHolding(s) in Company
1st Jul 201410:00 amRNSTotal Voting Rights
9th Jun 20142:00 pmRNSCompany Secretary Change
27th May 20147:00 amRNSUpdate on Shennong Joint Venture in China
15th May 20147:00 amRNSInterim Management Statement
15th May 20147:00 amRNSStrategic Beef Partnership with ABP Food Group
3rd Apr 20144:29 pmRNSDirector/PDMR Shareholding
28th Mar 20142:22 pmRNSDirector/PDMR Shareholding
19th Mar 20144:05 pmRNSBoard Appointments
17th Mar 20144:35 pmRNSDirector/PDMR Shareholding
25th Feb 20147:00 amRNSInterim Results
10th Feb 20147:00 amRNSCompletion of Acquisition of Genetiporc do Brasil
31st Jan 20142:00 pmRNSTotal Voting Rights
31st Jan 20142:00 pmRNSBlocklisting Interim Review
31st Dec 201312:41 pmRNSTotal Voting Rights
31st Dec 201312:41 pmRNSDirector/PDMR Shareholding
12th Dec 20133:00 pmRNSDirector/PDMR Shareholding
29th Nov 20135:01 pmRNSTotal Voting Rights
15th Nov 20133:02 pmRNSResult of AGM
15th Nov 20137:00 amRNSInterim Management Statement
31st Oct 20134:25 pmRNSTotal Voting Rights
29th Oct 20132:30 pmRNSHolding(s) in Company
18th Oct 20137:00 amRNSCompletion of Acquisition of Génétiporc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.